Identifying placental dysfunction in women with reduced fetal movements can be used to predict patients at increased risk of pregnancy complications

Medical Hypotheses

Volumn 76, Issue 1, 2011, Pages 17-20

  Warrander, Lynne K ^a   Heazell, Alexander E P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL PEPTIDE HORMONE;

ADVERSE OUTCOME; ARTICLE; BIOPHYSICS; CARDIOTOCOGRAPHY; CELL FUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ENVIRONMENT; FEMALE; FETUS MOVEMENT; HIGH RISK PREGNANCY; HUMAN; HYPOTHESIS; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MATERNAL SERUM; MICROSCOPY; NUTRIENT SUPPLY; OXYGEN SUPPLY; PLACENTA DISORDER; PREDICTION; PUBIS SYMPHYSIS; RELIABILITY; STILLBIRTH;

FEMALE; FETAL MOVEMENT; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 78650171250     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.08.020     Document Type: Article

References (47)

1. Confidential Enquiry into Maternal and Child Health, Perinatal Mortality 2007: England, Wales and Northern Ireland. 2009, Confidential Enquiry into Maternal and Child Health: London.
2. Gardosi J., et al. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005, 331(7525):1113-1117.
3. CEMACH. Confidential Enquiry into Maternal and Child Health (CEMACH) Perinatal Mortality 2007. London: CEMACH; 2009.
4. Heazell A.E., Froen J.F. Methods of fetal movement counting and the detection of fetal compromise. J Obstet Gynaecol 2008, 28(2):147-154.
5. Sadovsky E., Yaffe H. Daily fetal movement recording and fetal prognosis. Obstet Gynecol 1973, 41(6):845-850.
6. Heazell A.E., Sumathi G.M., Bhatti N.R. What investigation is appropriate following maternal perception of reduced fetal movements?. J Obstet Gynaecol 2005, 25(7):648-650.
7. Pearson J.F., Weaver J.B. Fetal activity and fetal wellbeing: an evaluation. Br Med J 1976, 1(6021):1305-1307.
8. Ehrstrom C. Fetal movement monitoring in normal and high-risk pregnancy. Acta Obstet Gynecol Scand Suppl 1979, 80:1-32.
9. Fischer S., Fullerton J.T., Trezise L. Fetal movement and fetal outcome in a low-risk population. J Nurse Midwifery 1981, 26(1):24-30.
10. Rayburn W.F. Clinical implications from monitoring fetal activity. Am J Obstet Gynecol 1982, 144(8):967-980.
11. Valentin L., Marsal K. Fetal movement in the third trimester of normal pregnancy. Early Hum Dev 1986, 14(3-4):295-306.
12. Whitty J.E., Garfinkel D.A., Divon M.Y. Maternal perception of decreased fetal movement as an indication for antepartum testing in a low-risk population. Am J Obstet Gynecol 1991, 165(4 Pt 1):1084-1088.
13. Dubiel M., et al. Doppler velocimetry and nonstress test for predicting outcome of pregnancies with decreased fetal movements. Am J Perinatol 1997, 14(3):139-144.
14. Sergent F., et al. Decreased fetal movements in the third trimester: what to do?. Gynecol Obstet Fertil 2005, 33(11):861-869.
15. Tveit J.V., et al. Reduction of late stillbirth with the introduction of fetal movement information and guidelines - a clinical quality improvement. BMC Pregnancy Childbirth 2009, 9:32.
16. O'Sullivan O., et al. Predicting poor perinatal outcome in women who present with decreased fetal movements. J Obstet Gynaecol 2009, 29(8):705-710.
17. Confidential, et al. Eighth Annual Report. London: Maternal and Child Health Research Consortium; 2001.
18. Heazell A.E., et al. Midwives' and obstetricians' knowledge and management of women presenting with decreased fetal movements. Acta Obstet Gynecol Scand 2008, 87(3):331-339.
19. Froen J.F., et al. Management of decreased fetal movements. Semin Perinatol 2008, 32(4):307-311.
20. Mangesi L, Hofmeyr GJ. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev 2007(1):CD004909.
21. Unterscheider J., et al. Reduced fetal movements. Obstetrician Gynaecol 2009, 11(4):245-251.
22. Vintzileos A.M., et al. Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 1991, 165(3):707-713.
23. Macara L., et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996, 17(1):37-48.
24. Heazell A.E., Martindale E.A. Can post-mortem examination of the placenta help determine the cause of stillbirth?. J Obstet Gynaecol 2009, 29(3):225-228.
25. Huppertz B. The anatomy of the normal placenta. J Clin Pathol 2008, 61(12):1296-1302.
26. Smith S.C., Baker P.N., Symonds E.M. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997, 177(6):1395-1401.
27. Levy R., et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 2002, 186(5):1056-1061.
28. Scifres C.M., Nelson D.M. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 2009, 587(Pt 14):3453-3458.
29. Chen C.-P., Bajoria R., Aplin J.D. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 2002, 187(3):764-769.
30. Kidron D., Bernheim J., Aviram R. Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta 2009, 30(8):700-704.
31. Parast M.M., Crum C.P., Boyd T.K. Placental histologic criteria for umbilical blood flow restriction in unexplained stillbirth. Hum Pathol 2008, 39(6):948-953.
32. Sibley C.P. Understanding placental nutrient transfer - why bother? New biomarkers of fetal growth. J Physiol 2009, 587(Pt 14):3431-3440.
33. Dicke J.M., Henderson G.I. Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci 1988, 295(3):223-227.
34. Sheikh S., Satoskar P., Bhartiya D. Expression of insulin-like growth factor-I and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol Hum Reprod 2001, 7(3):287-292.
35. Barrio E., et al. Study of apoptosis and related proteins, CRH and hpGH in placentas of newborns small for gestational age (SGA). Pediatr Endocrinol Rev 2009, 6(Suppl 3):337-342.
36. Shokry M., et al. Maternal serum placental growth factor and soluble FMS-like tyrosine kinase 1 as early predictors of preeclampsia. Acta Obstet Gynecol Scand 2010, 89(1):143-146.
37. Smith G.C., Fretts R.C. Stillbirth. Lancet 2007, 370(9600):1715-1725.
38. Giacoia G.P. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv 1997, 52(6):372-380.
39. Froen J.F. A kick from within-fetal movement counting and the cancelled progress in antenatal care. J Perinat Med 2004, 32(1):13-24.
40. Heazell AE, et al. Placental size is reduced and placental infarction and syncytial knots are increased in pregnancies complicated by decreased fetal movements. Placenta 2010; 31(suppl.), in press.
41. Chamberlain P.F., et al. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 1984, 150(3):245-249.
42. Smith G.C., et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002, 87(4):1762-1767.
43. Smith G.C., et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA 2004, 292(18):2249-2254.
44. Smith G.C., et al. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006, 107(1):161-166.
45. Chafetz I., et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007, 197(1):35. e1-7.
46. Smith G.C. Predicting antepartum stillbirth. Curr Opin Obstet Gynecol 2006, 18(6):625-630.
47. Heazell A.E., et al. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta 2008, 29(2):175-186.